TERT and head and neck squamous cell carcinoma: Instead, new therapeutic approaches that invigorate TERT-mediated T-B cooperation using, for example, autologous B lymphocytes engineered to express TERT, could represent the next frontier in the immunotherapy of HNSCC complementing existing T cell-centered immunotherapies (85).